
GlobalIndices
GlobalIndices 02‐Apr Prev_Day Abs.Change
%Change
#
DowJones 23,644 24,103 ‐459 ‐1.90
Nasdaq 6,870 7,063 ‐193 ‐2.74
FTSE Closed 7,057 NA NA
Nikkei 21,389 21,454 ‐66 ‐0.31
HangSeng Closed 30,093 NA NA
IndianIndices 02‐Apr Prev_Day Abs.Change
%Change
#
S&PBSESensex 33,255 32,969 287 0.87
Nifty50 10,212 10,114 98 0.97
Nifty100 10,596 10,478 118 1.12
NiftyBank 24,329 24,263 65 0.27
SGXNifty 10,262 10,160 102 1.00
S&PBSEPower 2 ,153 2,126 27 1.29
S&PBSESmallCap 17,394 16,994 400 2.35
S&PBSEHC 13,484 13,158 326 2.48
Date P/E Div.Yield P/E Div.Yield
2‐Apr 22.94 1.17 25.35 1.26
MonthAgo 23.61 1.16 25.59 1.19
YearAgo 22.63 1.36 23.26 1.25
Nifty50Top3Gainers
Company 02‐Apr Prev_Day
%Change
#
AurobindoPharma 593 558 6.22
Cipla 576 545 5.65
Lupin 777 736 5.61
Nifty50Top3Losers DomesticNews
Company 02‐Apr Prev_Day
%Change
#
ICICIBank 262 278 ‐5.93
IndianOil 170 177 ‐3.48
AxisBank 499 511 ‐2.24
AdvanceDeclineRatio
BSE NSE
Advances 2101 1493
Declines 537 312
Unchanged 173 55
InstitutionalFlows(Equity)
Description(Cr) YTD
FIIFlows* 14399
MFFlows** 30162
*28
th
Mar2018;**26
th
Mar2018
EconomicIndicator
YoY(%) Current YearAgo
WPI
2.48%
(Feb‐18)
5.51%
(Feb‐17)
IIP
7.50%
(Jan‐18)
3.00%
(Jan‐17)
GDP
7.20%
(Dec‐17)
6.80%
(Dec‐16)
03April2018
SinceMay‐17,MOSPIhasrevisedbaseyearofIIP&WPIfrom2004‐05to2011‐12,andforCPI
from2010to2012
IndianEquityMarket
IndicesPerformance
P/EDividendYield
Sensex Nifty
1.80%
(Oct‐17)
6.50%
(Sep‐17)
QuarterAgo
Inflow/Outflow
2250
1094
4.02%
(Nov‐17)
•Indianequitymarketsclosedinthegreenonthebackofgainsin
pharma and auto stocks. Jump in Mar 2018 vehicle sales of heavyweights
lead the gains. However, banking stocks fell amid reports that the Central
Bureau of Investigation (CBI) has launched a preliminary enquiry to verify
an Indian multinational banking and financial services company’s Rs.
40,000 crore loan to one of the industry majors.
• Key benchmark indices S&P BSE Sensex and Nifty 50 grew 0.87% and
0.97%, respectively, to close at 33,255.36 and 10,211.80. S&P BSE Mid‐
Cap and S&P BSE Small‐Cap fell 1.40% and 2 .35%.
• On the BSE sectoral front, S&P BSE Industrials was the major gainer, up
2.51%, followed by S&P B SE Healthcare that grew 2.48%. S &P BSE Aut o
and S&P BSE Capital Goods grew 2.14% and 2.03%, respectively. S&P BSE
Basic Materials and S&P BSE Consumer Discretionary Goods & Services
grew 2.01% and 1.64%, r espectively. A mong the lose rs, S&P BSE Bankex
was the major loser, down 0.37%, followed by S&P BSE Oil & Gas that fell
0.13%.
• Government data showed that the index of eight core industries grew
5.3% in Feb 2018 as against 6.1% in Jan 2018 (6.7% originally reported)
and 0.6% in Feb 2017. The month on month slowdown in pace of growth
reflects 2.4% and 1.5% decline in crude oil and natural gas products,
respectively. Meanwhile, cement witnessed maximum growth of 22.9%.
Data for Apr to Feb 2018 slowed to 4.3% from 4.7% in the same period of
2017.
• The government has sanctioned Goods and Services Tax (GST) refund of
80% of the eligible claims to ex p orters, which is worth about Rs. 12,700
crore. The Central Board of Excise and Customs (CBEC) had organised
refund facilitation camps in field offices between Mar 15‐31 t o assist
exporters in filling refund claim forms and correct e rrors.
• On the basis of requests received from stakeholders, the government
has given defaulting firms an extension for submitting filings under the
Companies Act, covered by the Condonation of Delay Scheme, till Apr 30,
2018, from M ar 31, 2018. Initially, the scheme was announced effective
Jan 1, 2018, for a three‐month period ending Mar 31, 2018, as a measure
to crackdown companies allegedly being used as conduits for illicit fun d
flowsaswellasthoseregisteredcompaniesthathavenotbeencarrying
out business activities for a long time period.
• Hyundai Motor India Ltd posted 8.8% YoY increase in total sales to
60,507 units in M ar 2018 from 55,614 units in Mar 2017. Domestic sales
and exports of the company arose by 7.3% and 15.1% YoY, respectively.
• Suzuki Motorcycle I ndia reported increase in sales by 23.2% Y oY to
51,858 units in Mar 2018. In FY18, the company posted growth of 43%
YoY in domestic market.
• Dr Reddy's Laboratories Limited along with its subsidiary, Promius
Pharma, has filed new drug application (NDA) with the U.S. health
regulator for its m igraine candidate DFN‐02.
• Most of the Asian markets traded in low amid thin trading session due
to Easter holidays. Weaker than expected economic data in China and
Japan also weighed on the sentiments. The Caixin survey revealed that
China's manufacturing activity grew at its slowest pace in four months in
Mar 2018 and Japan's business confidence deteriorated in the first
quarter. China also imposed tariffs on certain U.S. imports. Today (As of
April 03), Asian markets opened lower following decline on the Wall
Street overnight. Both Nikkei and Hang Seng were trading lower 1.04%
and 0.56%, respectively (as at 8 a.m. IST).
• As per the last close, European market was closed on account of Easter
Holiday.
• As per the last close, U.S markets fell on renewed trade war concerns
after China announced to impose tariffs on 128 imported goods
originating in the U.S. The move by China comes after the U.S. President’s
decided to impose tariffs on steel and aluminum imports. On the U.S.
economic front, ISM based manufacturing activity i n Mar 2018 grew at a
slower than forecast.
MarketsforYou